FDA Person
FDAStephanie C. Mangigian
View detailed information about Stephanie C. Mangigian, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 70 inspections of 69 companies, 2016–2024.
Inspections (70)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| October 24, 2024 | John Brandsema, M.D. | NAI | Bioresearch Monitoring | #1253737 |
| October 11, 2024 | ALTASCIENCES PRECLINICAL SCRANTON INC. | Not classified | #1252697 | |
| September 24, 2024 | Janssen Biotech Inc. | NAI | Bioresearch Monitoring | #1251380 |
| September 9, 2024 | David Weisman, M.D. | VAI | Bioresearch Monitoring: Human Drugs | #1248800 |
| July 18, 2024 | Inotiv | Not classified | #1246081 | |
| June 13, 2024 | Michael J. Strunc, M.D. | VAI | Bioresearch Monitoring | #1242847 |
| April 19, 2024 | James Harrop, M.D. | NAI | Bioresearch Monitoring | #1238097 |
| March 13, 2024 | Adaptimmune LLC | NAI | Bioresearch Monitoring | #1235394 |
| February 8, 2024 | Timothy J. Craig, DO | NAI | Bioresearch Monitoring | #1230017 |
| January 11, 2024 | ICON PLC | NAI | Bioresearch Monitoring | #1227181 |
| December 1, 2023 | Jonathan M Spergel MD PhD | NAI | Bioresearch Monitoring | #1224357 |
| November 9, 2023 | Global Hospital | NAI | Bioresearch Monitoring | #1226586 |
| November 3, 2023 | Cliantha Research Limited | NAI | Bioresearch Monitoring | #1226066 |
| October 13, 2023 | Eagle Pharmaceuticals | NAI | Bioresearch Monitoring | #1220703 |
| September 20, 2023 | AstraZeneca Pharmaceuticals LP | NAI | Bioresearch Monitoring | #1219696 |
| September 1, 2023 | John F. Tisdale, M.D. | NAI | Bioresearch Monitoring | #1217392 |
| August 4, 2023 | RadMD | NAI | Bioresearch Monitoring | #1215344 |
| June 28, 2023 | Turning Point Therapeutics Inc | NAI | Bioresearch Monitoring | #1209815 |
| May 19, 2023 | Marcia Waddington Cruz, M.D. | NAI | Bioresearch Monitoring | #1207471 |
| May 12, 2023 | Teresa P.M. Coelho, M.D. | NAI | Bioresearch Monitoring | #1207867 |
Documents (17)
- EIR · Frontage Laboratories Shanghai Co., Ltd. · March 8, 2013
- 483 · Mercy Catholic Medical Center Institutional Review Board · November 6, 2017
- EIR · Daniel Gruener · September 4, 2014
- EIR · Charles River Laboratories Inc · April 3, 2019
- EIR · PPD Development, L.P. · September 21, 2018
- EIR · Charles River Laboratories Inc · February 15, 2018
- 483 · University of Pennsylvania School of Veterinary Medicine (Penn Vet) · January 26, 2018
- EIR · Calvert Laboratories, Inc. · July 25, 2018
- 483 · Darrell White, M.D. · October 19, 2015
- 483 · Nina Gentile M.D · May 27, 2022
- EIR · IMMUNOCORE, LLC · October 14, 2021
- 483 · Calvin Pan · October 10, 2014
- 483 · Elizabeth Plimack, MD, MS · September 26, 2019
- 483 · Vemulkonda Koneti Rao, M.D. · October 7, 2022
- 483 · Bankole Johnson MD · October 28, 2020
- 483 · Marlex Pharmaceuticals, Inc. · August 12, 2021
- 483 · PLIVA Hrvatska d.o.o.
Frequently inspected with (9)
Anastasia I. Onuorah
investigator
4 shared
Kelly N. Kerr
investigator
3 shared
Brittany L. Carpenter
investigator
2 shared
Christopher Bastedo
investigator
1 shared
Gabrielle J. Swain
investigator
1 shared
Himanshu Gupta
issuing_officer
1 shared
Mark J. Seaton
issuing_officer
1 shared
Marshall A. Naimo
1 shared
Yiyue C. Zhang
1 shared
Person Information
Name
Stephanie C. Mangigian
Title
investigator
Role
COMPANY REP
ID: 0cf25e6b-1e5d-4088-a13c-11483e2380ba
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.